Apoptosis with Terpenoids:Treatment of Breast and Prostate Cancer
Terpenoids represent a large and diverse class of naturally occurring compounds found in a variety of fruits, vegetables and medicinal plants. Structurally some of the terpenoids are similar to human hormones. A diet rich in terpenoids is inversely related with the risk of chronic diseases including cancers. Breast and prostate cancers are hormone-related diseases and the second leading cause of female and male cancer mortality. Diterpenoid paclitaxel, and its semi-synthetic analogue docetaxel, have entered clinical use against established breast and prostate cancers. Here we reviewed potential molecular targets and biological properties of natural terpenoids, including monoterpenoids, diterpenoids, triterpenoids and tetraterpenoids, and their applications in treatment of human breast and prostate cancers. These terpenoids are able to inhibit tumor cell proliferation and induce tumor cell death by inhibiting multiple cancer-specific targets including the proteasome, NF-κB, and antiapoptoticSomething that prevents apoptosisa normal, genetically regulated process leading to the death of cells and triggered by the presence or absence of certain stimuli, as DNA damage. Apoptosisa normal, genetically regulated process leading to the death of cells and triggered by the presence or absence of certain stimuli, as DNA damage is a type of cell death in which a series of molecular steps in a cell leads to its death. protein Bcl-2. The efficacy of these terpenoids against breast or prostate cancer cells, as demonstrated in pre-clinical studies supports clinical application of these naturally occurring terpenoids in treatment of hormone-related human cancers.
Targeting Apoptosisa normal, genetically regulated process leading to the death of cells and triggered by the presence or absence of certain stimuli, as DNA damage Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer
Curr Drug Targets. 2010 Jun;11(6):733-44. Yang H, Dou QP.The Prevention Program, Barbara Ann Karmanos Cancer Institute, and Department of Oncology, School of Medicine, Wayne State University, Detroit, Michigan 48201, USA.